June 9, 2014 (Shareholders Foundation) - An investigation on behalf of investors of Humana Inc (NYSE:HUM) shares over potential securities laws violations by Humana and certain of its directors and officers in connection certain financial statements was announced.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Humana Inc (NYSE:HUM) concerning whether a series of statements by Humana regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

In May 2014 it was reported that Humana Inc. reportedly faces multiple federal investigations into allegations that it overbilled the government for treating elderly patients enrolled in its Medicare Advantage plans. One article stated that the investigations involve the U.S. Attorneys branch office in West Palm Beach, Fla., and the criminal division of the Justice Department in Washington concerning allegations of overbilling and fraud against Humana.

Humana Inc reported that its annual Total Revenue rose from over $33.59 billion in 2010 to over $41.31 billion in 2013 and that its respective Net Income increased from over $1.09 billion to over $1.23 billion. Shares of Humana Inc (NYSE:HUM) grew from $28.98 per share in July 2009 to as high as $125.66 per share on June 2, 2014.